Testing deep sedation for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This trial compares deep sedation methods during catheter ablation for atrial fibrillation. It aims to find which sedation approach is safer and more comfortable for people with AF who have not had this procedure before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have atrial fibrillation (paroxysmal, persistent, or long-standing) and are a candidate for catheter ablation
- You have not had a prior catheter ablation for AF or atrial septal defect repair
- Your left atrium is less than 55 mm in diameter and you do not have a clot in your left atrium
- Your kidney function is adequate (eGFR at least 30), and you do not have severe liver or bleeding problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a left atrial appendage closure device for people with atrial fibrillation who need an alternative to long-term blood thinners. It aims to see if the procedure can be done safely with conscious sedation instead of general anesthesia.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new type of catheter (Varipulse) to treat paroxysmal atrial fibrillation (AFib that comes and goes) using a procedure done under sedation. It aims to see if the catheter is safe and effective for people whose symptoms aren't controlled by medication.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.